Prior Authorization

As you are aware, many third-party payers require Prior Authorization for patients in need of important genetic and molecular laboratory testing. Without a Prior Authorization, your patient’s claim for reimbursement of the test will be rejected and they may receive a significant bill from HNL Genomics (CTGT) for this testing.

HNL Genomics (CTGT) will partner with you in obtaining Prior Authorization. While many insurers require that the health care professional ordering the test apply for Prior Authorization, HNL Genomics (CTGT) will work to submit the request on behalf of you and your patient (in most instances) so that testing can be authorized, performed and reimbursed without significant delay or co-payment required.

The Prior Authorization process requires that the insurance company is provided necessary clinical information to support the clinical need for the test. HNL Genomics (CTGT) has provided the attached form to easily collect the relevant information that we may convey to the insurance company. In some instances, this form may not answer all the questions that the insurance company requires. For this reason, our staff may contact your office for additional information if the insurance company requires it.

HNL Genomics (CTGT) also requires that all requests for genetic and molecular laboratory testing are accompanied by the attached Clinical History Form AND a recent pathology report, relevant clinic encounter notes or medical genetics consultation. HNL Genomics (CTGT) will process the patient’s specimen to ensure stability of the specimen but may HOLD the specimen and NOT complete the test until all information for the Prior Authorization is received.

Download the Prior Authorization Information packet

Helpful Tips

  • Prior Authorization for genetic and molecular laboratory testing is required by many, but not all, third party payers.

  • When HNL Genomics (CTGT) can bill the patient’s insurance directly for genetic and molecular laboratory testing, HNL Genomics (CTGT) will submit Prior Authorization requests.

  • In cases where HNL Genomics (CTGT) will be submitting the Prior Authorization request and billing the patient’s insurance, HNL Genomics (CTGT) requires completion of a Clinical History Form in addition to a test requisition.

  • HNL Genomics (CTGT)  will process and HOLD all specimens referred for genetic and molecular laboratory testing until ALL necessary clinical information for Prior Authorization submissions are received.

  • HNL Genomics (CTGT) reserves the right to bill the client or your patient for genetic and molecular laboratory testing in which Prior Authorization information is not received, or the third-party payer denies the request.

  • If Prior Authorization is denied, the ordering facility will be notified and given the option to cancel the test. If the test is canceled, a DNA extraction fee may apply.

  • Prior Authorization is not a guarantee of payment.

Frequently Asked Questions

Yes! If you complete the Clinical History Form, we can attempt the process for you.   (Prior Authorization)

Please contact HNL Genomics (CTGT) via 484-244-2900 or secure form (Prior Authorization). Our experts would be happy to assist you with all questions regarding Prior Authorization.

Clinical coverage reviews will be based on third party clinical policy requirements for coverage. These policies include clinical criteria and information about coverage eligibility for related services. If a request needs review or requires additional clinical information, we will contact the ordering health care professional.

Prior Authorization, also known as a pre-authorization or pre-certification, is a clause in the health insurance policy that says the patient must get permission from their health insurance company before they receive certain health care services which includes specialized laboratory testing. This process was developed to help ordering health care professionals, laboratories and their patients receive a quicker coverage determination by giving them information:

  • If a member’s benefit plan requires prior authorization.

  • When additional clinical information is required to make a coverage decision.

  • Whether the request meets third party’s clinical and coverage policy criteria.

Specialized laboratory testing that requires Prior Authorization can usually be found on the health plan’s website or by calling the health plan directly. Many genetic and molecular tests require Prior Authorization for outpatient services.

The health care professional who is ordering the testing is responsible for obtaining Prior Authorization for the specialized laboratory test. If the health care professional’s office does not obtain the necessary Prior Authorization before testing, the patient will be responsible for payment, which can range in cost from just under one hundred dollars to thousands of dollars based on the test ordered.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.


October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More